Trial intelligence / Profile preview

Etoricoxib dose-finding in knee osteoarthritis

NCT00242489Phase 2Completed

Sponsor
Organon & Co.
Start
Jun 1998
Primary completion
Feb 1999
Modality
Small Molecules
01

Overview

A Phase 2 trial of etoricoxib in knee osteoarthritis (OA), sponsored by Organon & Co.. Started Jun 1998; status: completed.

02

Drugs

etoricoxib
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00242489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00242489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call